These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gemcitabine-induced posterior reversible encephalopathy syndrome: a case report. Cioffi P; Laudadio L; Nuzzo A; Belfiglio M; Petrelli F; Grappasonni I J Oncol Pharm Pract; 2012 Jun; 18(2):299-302. PubMed ID: 22065198 [TBL] [Abstract][Full Text] [Related]
3. A case report of posterior reversible encephalopathy syndrome in a patient receiving gemcitabine and cisplatin. Cherniawsky H; Merchant N; Sawyer M; Ho M Medicine (Baltimore); 2017 Feb; 96(8):e5850. PubMed ID: 28225482 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature. How J; Blattner M; Fowler S; Wang-Gillam A; Schindler SE Neurologist; 2016 Nov; 21(6):112-117. PubMed ID: 27801773 [TBL] [Abstract][Full Text] [Related]
5. [Posterior reversible encephalopathy syndrome associated to chemotherapy. Gemcitabine as the causative agent]. Sanchez-Cendra C; Malon-Gimenez D; Guerra-Martinez JA; Calzas-Rodriguez J; Anton-Pascual B; Olmo-Sanchez A Rev Neurol; 2017 Jun; 64(12):574-575. PubMed ID: 28608357 [TBL] [Abstract][Full Text] [Related]
6. Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature. Rajasekhar A; George TJ Oncologist; 2007 Nov; 12(11):1332-5. PubMed ID: 18055853 [TBL] [Abstract][Full Text] [Related]
7. Posterior reversible encephalopathy syndrome possibly induced by pemetrexed maintenance therapy for lung cancer: a case report and literature review. Smets GJ; Loyson T; Van Paesschen W; Demaerel P; Nackaerts K Acta Clin Belg; 2018 Oct; 73(5):382-388. PubMed ID: 29173113 [TBL] [Abstract][Full Text] [Related]
10. Posterior reversible encephalopathy syndrome in a postpartum woman with acute lymphoblastic leukaemia after intrathecal methotrexate. Mescher C; Slungaard A BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978582 [TBL] [Abstract][Full Text] [Related]
11. Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature. Deguchi S; Mitsuya K; Nakasu Y; Hayashi N; Katagiri H; Murata H; Wasa J; Takahashi M; Endo M Invest New Drugs; 2018 Apr; 36(2):346-349. PubMed ID: 29067537 [TBL] [Abstract][Full Text] [Related]
12. Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia. Rangi PS; Partridge WJ; Newlands ES; Waldman AD Neuroradiology; 2005 Aug; 47(8):586-90. PubMed ID: 15997391 [TBL] [Abstract][Full Text] [Related]
15. Posterior reversible encephalopathy syndrome during convalescence from COVID-19. Michel-Chávez A; García-Grimshaw M; Chávez-Martínez OA; Cantú-Brito C; Romero-Sánchez GT; Flores-Silva FD; Merayo-Chalico FJ; Martínez-Carrillo FM; Barrera-Vargas A; Valdés-Ferrer SI Int J Neurosci; 2023 Jun; 133(6):672-675. PubMed ID: 34370958 [No Abstract] [Full Text] [Related]
16. Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy. Tsukamoto S; Takeuchi M; Kawajiri C; Tanaka S; Nagao Y; Sugita Y; Yamazaki A; Kawaguchi T; Muto T; Sakai S; Takeda Y; Ohwada C; Sakaida E; Shimizu N; Yokote K; Iseki T; Nakaseko C Int J Hematol; 2012 Feb; 95(2):204-8. PubMed ID: 22160836 [TBL] [Abstract][Full Text] [Related]
17. Posterior reversible encephalopathy syndrome (PRES): a rare condition after resection of posterior fossa tumors: two new cases and review of the literature. González Quarante LH; Mena-Bernal JH; Martín BP; Ramírez Carrasco M; Muñoz Casado MJ; Martínez de Aragón A; de las Heras RS Childs Nerv Syst; 2016 May; 32(5):857-63. PubMed ID: 26584552 [TBL] [Abstract][Full Text] [Related]
20. Posterior reversible encephalopathy syndrome in the emergency department: A single center retrospective study. Miller R; Wagner S; Hammond J; Roberts N; Marshall K; Barth B Am J Emerg Med; 2021 Jul; 45():61-64. PubMed ID: 33667750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]